Clinical Trial

Cryotherapy in the Treatment of Desmoid Tumors

Recruiting
View on ClinicalTrials.gov →
Summary
Desmoid tumor is a benign neoplasm with an unpredictable course and a high rate of local recurrence if treated surgically. Therefore, over time the surgical approach has become conservative, preferring simple observation or medical therapy in case of disease progression through the use of hormonal therapy and low-dose chemotherapy. Since this neoplasm remains benign, our study aims to avoid chemotherapy in patients usually young through the use of a minimally invasive treatment such as cryotherapy.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-10-12; most recent amendment 2025-07-29.
Trial Details
NCT Number NCT05091255
Lead Sponsor Istituto Ortopedico Rizzoli
Conditions Desmoid
Enrollment 94 participants
Start Date 2021-05-20
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-01